18.42
-0.58 (-3.05%)
| Penutupan Terdahulu | 19.00 |
| Buka | 18.89 |
| Jumlah Dagangan | 1,213,288 |
| Purata Dagangan (3B) | 1,004,276 |
| Modal Pasaran | 1,281,271,296 |
| Harga / Pendapatan (P/E TTM) | 8.19 |
| Harga / Pendapatan (P/E Ke hadapan) | 9.69 |
| Harga / Jualan (P/S) | 3.88 |
| Harga / Buku (P/B) | 1.88 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Apr 2025 - 5 May 2025 |
| Margin Keuntungan | 45.91% |
| Margin Operasi (TTM) | 28.48% |
| EPS Cair (TTM) | 2.25 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -22.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 50.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.11% |
| Nisbah Semasa (MRQ) | 10.23 |
| Aliran Tunai Operasi (OCF TTM) | 132.66 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 78.31 M |
| Pulangan Atas Aset (ROA TTM) | 8.53% |
| Pulangan Atas Ekuiti (ROE TTM) | 24.31% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | InMode Ltd. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | 0.75 |
|
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 13.95% |
| % Dimiliki oleh Institusi | 65.56% |
| Julat 52 Minggu | ||
| Median | 29.00 (57.44%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 05 Feb 2025 | 29.00 (57.44%) | Beli | 17.96 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 26 Mar 2025 | Pengumuman | InMode to Present at the 24th Annual Needham Virtual Healthcare Conference |
| 06 Mar 2025 | Pengumuman | InMode Responds to Doma Perpetual's Letters |
| 03 Mar 2025 | Pengumuman | InMode to Present at Upcoming Investor Conferences |
| 04 Feb 2025 | Pengumuman | InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program |
| 03 Feb 2025 | Pengumuman | InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference |
| 16 Jan 2025 | Pengumuman | InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced |
| 15 Jan 2025 | Pengumuman | DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |